Evidence map›Paper›PMID 32188632›Full record

ArticleDevelopment (Cambridge, England)2020

Lymphatics in bone arise from pre-existing lymphatics.

Marco Monroy, Anna L McCarter, Devon Hominick, Nina Cassidy, Michael T Dellinger

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. VEGF-D-induced intraosseous lymphangiogenesis drives site-specific heterotopic bone resorption.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Lymphatic vasculature in the central nervous system.Frontiers in cell and developmental biology · 2023
    Review
  19. Fin ray branching is defined by TRAPProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marco MonroyDivision of Surgical Oncology, Department of Surgery and The Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Anna L McCarterDivision of Surgical Oncology, Department of Surgery and The Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Devon HominickDivision of Surgical Oncology, Department of Surgery and The Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Nina CassidyDivision of Surgical Oncology, Department of Surgery and The Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Michael T DellingerDivision of Surgical Oncology, Department of Surgery and The Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA michael.dellinger@utsouthwestern.edu.ORCID 0000-0002-3315-4239
Southwestern Medical Center · US

Funding

Characterizing the Formation and Function of Bone LymphaticsR01HL144793 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI DELLINGER, MICHAEL THOMAS · 2019 to 2022
$1.6M
NHLBI NIH HHS R01 HL144793
6 · The paper itself

Abstract

Bones do not normally have lymphatics. However, individuals with generalized lymphatic anomaly (GLA) or Gorham-Stout disease (GSD) develop ectopic lymphatics in bone. Despite growing interest in the development of tissue-specific lymphatics, the cellular origin of bone lymphatic endothelial cells (bLECs) is not known and the development of bone lymphatics has not been fully characterized. Here, we describe the development of bone lymphatics in mouse models of GLA and GSD. Through lineage-tracing experiments, we show that bLECs arise from pre-existing Prox1-positive LECs. We show that bone lymphatics develop in a stepwise manner where regional lymphatics grow, breach the periosteum and then invade bone. We also show that the development of bone lymphatics is impaired in mice that lack osteoclasts. Last, we show that rapamycin can suppress the growth of bone lymphatics in our models of GLA and GSD. In summary, we show that bLECs can arise from pre-existing LECs and that rapamycin can prevent the growth of bone lymphatics.

Indexed as

AnimalsBone and BonesCell LineageCell ProliferationEndothelial CellsHomeodomain ProteinsHumansIntegrasesLymphatic VesselsMice, TransgenicMutationOsteoclastsPhosphatidylinositol 3-KinasesProspero-Related Homeobox 1 ProteinSirolimusSp7 Transcription FactorCre recombinaseHomeodomain ProteinsIntegrasesPhosphatidylinositol 3-KinasesProspero-Related Homeobox 1 ProteinSirolimusSp7 protein, mouseSp7 Transcription FactorTumor Suppressor ProteinsVascular Endothelial Growth Factor AGeneralized lymphatic anomalyGorham-Stout diseasePIK3CARapamycinVEGF-C

Identifiers

PMID32188632
PMCPMC7188445
OpenAlexW3011066758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.